|
Your search returned 250 studies:
- A Collaborative Model to Improve Blood Pressure (BP) Control and Minimize Racial Disparities - NCT00935077-52242
Conditions: Hypertension - Asthma
Location: Iowa City, IA
- A Pharmacodynamic Study to Evaluate the Effect of a Fixed Dose Combination Pill on Blood Pressure - NCT01005290-
Conditions: Hypertension
Location: New York, NY
- A Phase 2 Study of Punctal Placement of the Latanoprost Punctal Plug Delivery System (L-PPDS) - NCT00821002-94025
Conditions: Open-Angle Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90013
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90025
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90057
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Los Angeles, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90247
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Gardena, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90505
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Torrance, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90630
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Cypress, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-90806
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Long Beach, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-91105
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Pasadena, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-92663
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Newport Beach, CA
- A Phase 2 Study Of The 24-Hour Intraocular Pressure Lowering And Systemic Exposure Of PF-04217329 - NCT00934089-92844
Conditions: Glaucoma, Open-Angle - Ocular Hypertension
Location: Garden Grove, CA
- A Pilot Observational Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients - NCT00952081-10031
Conditions: Hypertension - Brain Tumor - Epilepsy
Location: New York, NY
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-15212
Conditions: Hypertension, Pulmonary
Location: Pittsburgh, PA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-19141
Conditions: Hypertension, Pulmonary
Location: Philadelphia, PA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-30030
Conditions: Hypertension, Pulmonary
Location: Decatur, GA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-30033
Conditions: Hypertension, Pulmonary
Location: Decatur, GA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-32610
Conditions: Hypertension, Pulmonary
Location: Gainesville, FL
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-34233
Conditions: Hypertension, Pulmonary
Location: Sarasota, FL
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-34239
Conditions: Hypertension, Pulmonary
Location: Sarasota, FL
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-68131
Conditions: Hypertension, Pulmonary
Location: Omaha, NE
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-75390
Conditions: Hypertension, Pulmonary
Location: Dallas, TX
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-85006
Conditions: Hypertension, Pulmonary
Location: Phoenix, AZ
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-85020
Conditions: Hypertension, Pulmonary
Location: Phoenix, AZ
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-92663
Conditions: Hypertension, Pulmonary
Location: Newport Beach, CA
- A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension - NCT00853112-92708
Conditions: Hypertension, Pulmonary
Location: Fountain Valley, CA
- A Safety Study of the Latanoprost Punctal Plug Delivery System (L-PPDS) in Subjects With Ocular Hypertension or Open Angle Glaucoma - NCT00820300-94025
Conditions: Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure - NCT00662753-20018
Conditions: Hypertension
Location: Washington, DC
- A Study in the Use of Home Blood Pressure Monitoring and Telephone Follow-up to Control Blood Pressure - NCT00662753-20032
Conditions: Hypertension
Location: Washington, DC
- A Study of Different Formulations of the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma - NCT00967811-94025
Conditions: Glaucoma - Ocular Hypertension
Location: Menlo Park, CA
- A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese Hypertensives - NCT00825188-39216
Conditions: Obesity - Hypertension
Location: Jackson, MS
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-10451
Conditions: Hypertension
Location: Bronx, NY
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-12553
Conditions: Hypertension
Location: New Windsor, NY
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-30312
Conditions: Hypertension
Location: Atlanta, GA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33012A
Conditions: Hypertension
Location: Hialeah, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33012B
Conditions: Hypertension
Location: Hialeah, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33014
Conditions: Hypertension
Location: Miami, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33024
Conditions: Hypertension
Location: Pembroke Pines, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33027
Conditions: Hypertension
Location: Pembroke Pines, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33134
Conditions: Hypertension
Location: Coral Gables, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33156
Conditions: Hypertension
Location: Miami, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-33169
Conditions: Hypertension
Location: Miami, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-34741
Conditions: Hypertension
Location: Kissimmee, FL
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-75006
Conditions: Hypertension
Location: Carrollton, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-78224
Conditions: Hypertension
Location: San Antonio, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-78229
Conditions: Hypertension
Location: San Antonio, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-78404
Conditions: Hypertension
Location: Corpus Christi, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-79902
Conditions: Hypertension
Location: El Paso, TX
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-90057
Conditions: Hypertension
Location: Los Angeles, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-90620
Conditions: Hypertension
Location: Buena Park, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-90806
Conditions: Hypertension
Location: Long Beach, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-91710
Conditions: Hypertension
Location: Chino, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-91950
Conditions: Hypertension
Location: National City, CA
- A Study on the Efficacy and Safety of Nebivolol Monotherapy in Hispanic Hypertensive Patients. - NCT00770861-92780
Conditions: Hypertension
Location: Tustin, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-
Conditions: Pulmonary Hypertension
Location: Baltimore, MD
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-02114
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-15212
Conditions: Pulmonary Hypertension
Location: Pittsburgh, PA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-30030
Conditions: Pulmonary Hypertension
Location: Decatur, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-33136
Conditions: Pulmonary Hypertension
Location: Miami, FL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-35294
Conditions: Pulmonary Hypertension
Location: Birmingham, AL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-36617
Conditions: Pulmonary Hypertension
Location: Mobile, AL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-43210
Conditions: Pulmonary Hypertension
Location: Columbus, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-44195
Conditions: Pulmonary Hypertension
Location: Cleveland, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-45014
Conditions: Pulmonary Hypertension
Location: Fairfield, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-75390
Conditions: Pulmonary Hypertension
Location: Dallas, TX
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-80045
Conditions: Pulmonary Hypertension
Location: Aurora, CO
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-92103
Conditions: Pulmonary Hypertension
Location: San Diego, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH. - NCT00855465-95817
Conditions: Pulmonary Hypertension
Location: Sacramento, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-02111
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-02114
Conditions: Pulmonary Hypertension
Location: Boston, MA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-15212
Conditions: Pulmonary Hypertension
Location: Pittsburgh, PA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-30030
Conditions: Pulmonary Hypertension
Location: Decatur, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-30322
Conditions: Pulmonary Hypertension
Location: Atlanta, GA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-33136
Conditions: Pulmonary Hypertension
Location: Miami, FL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-36617
Conditions: Pulmonary Hypertension
Location: Mobile, AL
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-43210
Conditions: Pulmonary Hypertension
Location: Columbus, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-44195
Conditions: Pulmonary Hypertension
Location: Cleveland, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-45014
Conditions: Pulmonary Hypertension
Location: Fairfield, OH
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-55905
Conditions: Pulmonary Hypertension
Location: Rochester, MN
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-75390
Conditions: Pulmonary Hypertension
Location: Dallas, TX
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-80045
Conditions: Pulmonary Hypertension
Location: Aurora, CO
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-90073
Conditions: Pulmonary Hypertension
Location: Los Angeles, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-90502
Conditions: Pulmonary Hypertension
Location: Torrance, CA
- A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00810693-95817
Conditions: Pulmonary Hypertension
Location: Sacramento, CA
- A Study to Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6 - 17 Years of Age - NCT00834041-
Conditions: Hypertension
Location: Daytona Beach, FL
- Acupuncture and Laser Acupoint Treatment on Hypertension - NCT00459680-63017
Conditions: Hypertension
Location: Chesterfield, MO
- ADMA Levels in End-Stage Renal Disease - NCT00350974-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Aerobic Exercise in Patients With Pulmonary Hypertension - NCT00678821-20892
Conditions: Hypertension, Pulmonary
Location: Bethesda, MD
- Aerobic Exercise in Patients With Pulmonary Hypertension - NCT00678821-22042
Conditions: Hypertension, Pulmonary
Location: Falls Church, VA
- After Discharge Management of Low Income Frail Elderly - NCT00328848-44304
Conditions: Heart Failure, Congestive - Coronary Arteriosclerosis - Atrial Fibrillation - Cerebrovascular Accident - Pulmonary Disease, Chronic Obstructive - Diabetes Mellitus - Hypertension - Osteoarthritis - Osteoporosis
Location: Akron, OH
- Aldosterone Blockade to Prevent Myocardial Remodeling In Patients With Controlled Essential Hypertension - NCT00980031-68131
Conditions: Myocardial Remodeling
Location: Omaha, NE
- Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus - NCT00927394-
Conditions: Hypertension
Location: Philadelphia, PA
- Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension - NCT00797316-08402
Conditions: Hypertension
Location: Margate City, NJ
- Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension - NCT00797316-08753
Conditions: Hypertension
Location: Toms River, NJ
- Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension - NCT00797316-10469
Conditions: Hypertension
Location: Bronx, NY
- Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension - NCT00797316-19067
Conditions: Hypertension
Location: Morrisville, PA
- Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension - NCT00797316-63110
Conditions: Hypertension
Location: North Chicago, IL
- Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension - NCT00797316-65807
Conditions: Hypertension
Location: Springfield, MO
- Alpha-Adrenoceptor Vascular Function In Chronic Kidney Disease Focus On The Role Of Endothelial Nitric Oxide - NCT00356265-48109
Conditions: Chronic Kidney Disease - Hypertension
Location: Ann Arbor, MI
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension - NCT00851929-
Conditions: Sarcoidosis - Pulmonary Hypertension
Location: Chapel Hill, NC
- Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension - NCT00851929-29466
Conditions: Sarcoidosis - Pulmonary Hypertension
Location: Charleston, SC
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-40202
Conditions: Hypertension
Location: Louisville, KY
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-44106
Conditions: Hypertension
Location: Cleveland, OH
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-72202
Conditions: Hypertension
Location: Little Rock, AR
- Ambulatory Blood Pressure Monitoring in Hypertension - NCT00166634-84132
Conditions: Hypertension
Location: Salt Lake City, UT
- An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects - NCT00811564-
Conditions: Glaucoma - Ocular Hypertension
Location: Slingerlands, NY
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-30030
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Decatur, GA
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-33756
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Clearwater, FL
- ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00879229-45219
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Cincinnati, OH
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-15212
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-48202
Conditions: Pulmonary Arterial Hypertension
Location: Detroit, MI
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-77030
Conditions: Pulmonary Arterial Hypertension
Location: Houston, TX
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-78229
Conditions: Pulmonary Arterial Hypertension
Location: San Antonio, TX
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension - NCT00323297-90073
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Atenolol Exposure as Risk for Adverse Metabolic Responses to Beta Blockers - NCT00607347-32610
Conditions: Hypertension
Location: Gainesville, FL
- Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS) - NCT00455403-63110
Conditions: Metabolic Syndrome X - Overweight - Hypertension - Dyslipidemias - Prediabetic State
Location: St. Louis, MO
- Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions - NCT00081731-43614
Conditions: Atherosclerosis - Cardiovascular Diseases - Hypertension, Renovascular - Renal Artery Obstruction
Location: Toledo, OH
- Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension - NCT00913094-48201
Conditions: Hypertension
Location: Detroit, MI
- Biomarkers in the Evaluation of Chronic Lung Disease - NCT00926523-11040
Conditions: Pulmonary Hypertension - Pulmonary Arterial Hypertension - Interstitial Lung Disease
Location: New Hyde Park, NY
- Black Education and Treatment of Hypertension (BEAT HTN) - NCT00661895-68104
Conditions: Hypertension
Location: Omaha, NE
- Body Volume Regulation in Pulmonary Arterial Hypertenison With Right Ventricular Failure - NCT00811486-80262
Conditions: Right Heart Failure - Pulmonary Hypertension
Location: Denver, CO
- B-type Natriuretic Peptide (BNP) in Human Hypertension - NCT00953472-55905
Conditions: Hypertension Stage 1
Location: Rochester, MN
- Cardiopulmonary Function Assessment and NO-Based Therapies for Patients With Hemolysis-Associated Pulmonary Hypertension - NCT00352430-20892
Conditions: Pulmonary Hypertension
Location: Bethesda, MD
- Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured Patients - NCT00125229-78229
Conditions: Traumatic Brain Injury - Intracranial Hypertension
Location: San Antonio, TX
- Changes in Eye Pressure and Anterior Chamber Depth With Oral Endothelin Antagonist Therapy - NCT00452283-80045
Conditions: Glaucoma - Pulmonary Hypertension
Location: Aurora, CO
- Chloroquine to Treat People With Metabolic Syndrome (ARCH-MS) - NCT00455325-63110
Conditions: Metabolic Syndrome X - Overweight - Hypertension - Dyslipidemias - Prediabetic State
Location: St. Louis, MO
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-60614
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: Chicago, IL
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-90027
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: Los Angeles, CA
- Chronic Sildenafil for Severe Diaphragmatic Hernia - NCT00133679-94143
Conditions: Hernia, Diaphragmatic - Hypertension, Pulmonary - Hypoplasia, Pulmonary
Location: San Francisco, CA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-11794
Conditions: Hypertension - Heart Failure
Location: Stony Brook, NY
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-27710
Conditions: Hypertension - Heart Failure
Location: Durham, NC
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-37232
Conditions: Hypertension - Heart Failure
Location: Nashville, TN
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-44109
Conditions: Hypertension - Heart Failure
Location: Cleveland, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-44195
Conditions: Hypertension - Heart Failure
Location: Cleveland, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-45267
Conditions: Hypertension - Heart Failure
Location: Cincinnati, OH
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-48202
Conditions: Hypertension - Heart Failure
Location: Detroit, MI
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-63110
Conditions: Hypertension - Heart Failure
Location: St. Louis, MO
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-70112
Conditions: Hypertension - Heart Failure
Location: New Orleans, LA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-70805
Conditions: Hypertension - Heart Failure
Location: Baton Rouge, LA
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-75390
Conditions: Hypertension - Heart Failure
Location: Dallas, TX
- Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure - NCT00803634-90301
Conditions: Hypertension - Heart Failure
Location: Inglewood, CA
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-10032
Conditions: Hypertension - Hemorrhage
Location: New York, NY
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-19107
Conditions: Hypertension - Hemorrhage
Location: Philadelphia, PA
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-20010
Conditions: Hypertension - Hemorrhage
Location: Washington, DC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-21287
Conditions: Hypertension - Hemorrhage
Location: Baltimore, MD
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-27405
Conditions: Hypertension - Hemorrhage
Location: Greensboro, NC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-27710
Conditions: Hypertension - Hemorrhage
Location: Durham, NC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-29425A
Conditions: Hypertension - Hemorrhage
Location: Charleston, SC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-29425B
Conditions: Hypertension - Hemorrhage
Location: Charleston, SC
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-43210
Conditions: Hypertension - Hemorrhage
Location: Columbus, OH
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-44195
Conditions: Hypertension - Hemorrhage
Location: Cleveland, OH
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-48202
Conditions: Hypertension - Hemorrhage
Location: Detroit, MI
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-77030
Conditions: Hypertension - Hemorrhage
Location: Houston, TX
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-78229
Conditions: Hypertension - Hemorrhage
Location: San Antonio, TX
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-84157
Conditions: Hypertension - Hemorrhage
Location: Murray, UT
- Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage - NCT00666328-96813
Conditions: Hypertension - Hemorrhage
Location: Honolulu, HI
- Clinical Decision Support Consortium - NCT00853619-02481
Conditions: Diabetes - Coronary Artery Disease - Hypertension
Location: Wellesley, MA
- Cocoa, Polyphenols, and the Kidney in Healthy Subjects and in Subjects With Hypertension and Diabetes Mellitus - NCT00639665-02115
Conditions: Diabetes
Location: Boston, MA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-02115
Conditions: Pulmonary Arterial Hypertension
Location: Boston, MA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-10032
Conditions: Pulmonary Arterial Hypertension
Location: New York, NY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-14203
Conditions: Pulmonary Arterial Hypertension
Location: Buffalo, NY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-15213A
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-15213B
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-19713
Conditions: Pulmonary Arterial Hypertension
Location: Newark, DE
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-21201
Conditions: Pulmonary Arterial Hypertension
Location: Baltimore, MD
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-23507
Conditions: Pulmonary Arterial Hypertension
Location: Norfolk, VA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-30030
Conditions: Pulmonary Arterial Hypertension
Location: Decatur, GA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-30322
Conditions: Pulmonary Arterial Hypertension
Location: Atlanta, GA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-32258
Conditions: Pulmonary Arterial Hypertension
Location: Jacksonville, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33136
Conditions: Pulmonary Arterial Hypertension
Location: Miami, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33331
Conditions: Pulmonary Arterial Hypertension
Location: Weston, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-33756
Conditions: Pulmonary Arterial Hypertension
Location: Clearwater, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-34239
Conditions: Pulmonary Arterial Hypertension
Location: Sarasota, FL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-35294
Conditions: Pulmonary Arterial Hypertension
Location: Birmingham, AL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-36617
Conditions: Pulmonary Arterial Hypertension
Location: Mobile, AL
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-40202
Conditions: Pulmonary Arterial Hypertension
Location: Louisville, KY
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-43210
Conditions: Pulmonary Arterial Hypertension
Location: Columbus, OH
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-44195
Conditions: Pulmonary Arterial Hypertension
Location: Cleveland, OH
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-53226
Conditions: Pulmonary Arterial Hypertension
Location: Milwaukee, WI
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-55905
Conditions: Pulmonary Arterial Hypertension
Location: Rochester, MN
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-63110
Conditions: Pulmonary Arterial Hypertension
Location: St. Louis, MO
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-73112
Conditions: Pulmonary Arterial Hypertension
Location: Oklahoma City, OK
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-75390
Conditions: Pulmonary Arterial Hypertension
Location: Dallas, TX
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-77030
Conditions: Pulmonary Arterial Hypertension
Location: Houston, TX
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-84604
Conditions: Pulmonary Arterial Hypertension
Location: Provo, UT
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-90048
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-90095
Conditions: Pulmonary Arterial Hypertension
Location: Los Angeles, CA
- Combination Therapy in Pulmonary Arterial Hypertension - NCT00433329-97220
Conditions: Pulmonary Arterial Hypertension
Location: Portland, OR
- Combined Renin Inhibition/Beta-Blockade - NCT00627861-10021
Conditions: Hypertension
Location: New York, NY
- Comparative Effects of Nebivolol and Metoprolol on Femal Sexual Function - NCT00995072-32223
Conditions: Hypertension - Female Sexual Dysfunction
Location: Jacksonville, FL
- Comparative Effects of Nebivolol Versus Placebo on Sodium Sensitivity of Blood Pressure in Hispanic Postmenopausal Women With Hypertension - NCT00992056-33136
Conditions: Hypertension
Location: 1500 NW 12th Ave 15-West. Miam, FL
- Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects - NCT00735449-
Conditions: Glaucoma - Ocular Hypertension
Location: Newark, NJ
- Comparing the Effects of Two Beta Blockers,Metoprolol and Nebivolol,on Ambulatory Blood Pressure and Basal Metabolic Rate - NCT00849810-39216
Conditions: Hypertension
Location: Jackson, MS
- Comparison Fetal Hemodynamic Measurements Antihypertensive Versus Control - NCT00759278-13202
Conditions: Hypertension - Pregnancy
Location: Syracuse, NY
- Coreg CR, Blood Vessel Stiffness and Blood Vessel Function - NCT00732511-11203
Conditions: Endothelial Function - Diabetes Mellitus - Hypertension
Location: Brooklyn, NY
- Dallas Heart Study 2: Return Clinic Visit for the Dallas Heart Study Cohort - NCT00344903-75390
Conditions: Atherosclerosis - Congestive Heart Failure - Left Ventricular Hypertrophy - Diabetes Mellitus - Hypertension - Obesity - Metabolic Syndrome X - Myocardial Infarction
Location: Dallas, TX
- DHA Supplements to Improve Insulin Sensitivity in Obese Pregnant Women (The Omega-3 Pregnancy Study) - NCT00865683-45229
Conditions: Overweight and Obesity - Insulin Resistance - Diabetes, Gestational - Hypertension in Pregnancy - Pre-Eclampsia
Location: Cincinnati, OH
- Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease - NCT00984308-06516
Conditions: Obstructive Sleep Apnea - Hypertension
Location: West Haven, CT
- Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease - NCT00984308-46202
Conditions: Obstructive Sleep Apnea - Hypertension
Location: Indianapolis, IN
- Does Sildenafil Increase Exercise Performance in Air Pollution? - NCT00808912-18509
Conditions: Pulmonary Hypertension - Pulmonary Artery Pressure - Exercise Performance - Air Pollution
Location: Scranton, PA
- Dose Response of Valsartan on Sitting Systolic Blood Pressure in Children 6 Months - 5 Years of Age With High Blood Pressure - NCT00435162-
Conditions: Hypertension
Location: Charleston, WV
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-15212
Conditions: Pulmonary Arterial Hypertension
Location: Pittsburgh, PA
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-75390
Conditions: Pulmonary Arterial Hypertension
Location: Dallas, TX
- Dose-response Study of the Safety and Efficacy of Beraprost Sodium Modified Release (BPS-MR) in Patients With Pulmonary Arterial Hypertension (PAH) - NCT00989963-90502
Conditions: Pulmonary Arterial Hypertension
Location: Torrance, CA
- DuoTrav APS Versus XALACOM® in Ocular Surface Health - NCT00912054-76134
Conditions: Open Angle Glaucoma - Ocular Hypertension
Location: Fort Worth, TX
- DuoTrav® Eye Drops As Replacement Therapy Program - NCT00828906-76134
Conditions: Open-Angle Glaucoma - Ocular Hypertension
Location: Fort Worth, TX
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-02118
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Boston, MA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-06030
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Farmington, CT
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-11042
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Lake Success, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-12206
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Albany, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-14618
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Rochester, NY
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-19107
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Philadelphia, PA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-20007
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Washington, DC
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-21224
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Baltimore, MD
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-28401
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Wilmington, NC
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-29425
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Charleston, SC
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-32209
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Jacksonville, FL
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-35294
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Birmingham, AL
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-43614
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Toledo, OH
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-48106
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Ann Arbor, MI
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-49546
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Grand Rapids, MI
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-53226
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Milwaukee, WI
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-55455
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Minneapolis, MN
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-55905
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Rochester, MN
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-60612
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Chicago, IL
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-90095
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Los Angeles, CA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-90509
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Torrance, CA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-98101
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Seattle, WA
- Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc) - NCT00706082-99204
Conditions: Systemic Sclerosis - Pulmonary Arterial Hypertension - Pulmonary Hypertension
Location: Spokane, WA
- Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure - NCT00669279-32610
Conditions: Hypertension
Location: Gainesville, FL
- Effect of EGCG on the Body's Response to Insulin - NCT00434499-20892
Conditions: Hypertension - Obesity - Type 2 Diabetes - Insulin Resistance
Location: Bethesda, MD
- Effect of Electro-Acupuncture on Blood Pressure - NCT00932139-92697
Conditions: Hypertension - Arrhythmias
Location: Irvine, CA
- Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension - NCT00675051-94143
Conditions: Pulmonary Hypertension
Location: San Francisco, CA
- Effect of Exercise and Diet on Inflammation in Hypertensive Individuals - NCT00338572-92103
Conditions: Hypertension
Location: San Diego, CA
- Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries - NCT00935766-80204
Conditions: Metabolic Diseases - Endocrine System Diseases - Heart Disease - Vascular Diseases - Diabetes - Cardiovascular Disease - Glucose Metabolism Disorders - Hypertension
Location: Denver, CO
- Effect of High Blood Pressure and Antihypertensive Treatment on Brain Functioning in Children - NCT00178490-14642
Conditions: Hypertension
Location: Rochester, NY
- Effect of Low Socionomic Status and Psychosocial Factors on Cardiovascular Disease Risk in Mexican-American Women - NCT00387166-92123
Conditions: Hypertension - Cardiovascular Diseases
Location: San Diego, CA
- Effect of Sitagliptin and an ACE Inhibitor on Blood Pressure in Metabolic Syndrome - NCT00666848-37232
Conditions: Metabolic Syndrome - Hypertension
Location: Nashville, TN
- Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension - NCT00973531-19141A
Conditions: Sleep Apnea - Hypertension
Location: Philadelphia, PA
- Effect of Treating Sleep Disorder Breathing in Patients With Resistant Hypertension - NCT00973531-19141B
Conditions: Sleep Apnea - Hypertension
Location: Philadelphia, PA
- Effects of Almonds on Vascular Reactivity in Patients With Coronary Artery Disease - NCT00782015-02111
Conditions: Vascular Disease - Endothelial Dysfunction - Heart Disease - Cardiovascular Diseases - Hypertension
Location: Boston, MA
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00703339-22042
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Falls Church, VA
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00703339-37232
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Nashville, TN
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00703339-48109
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Ann Arbor, MI
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00703339-75390
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Dallas, TX
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00703339-92037
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: La Jolla, CA
- Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis - NCT00703339-95817
Conditions: Idiopathic Pulmonary Fibrosis - Pulmonary Hypertension
Location: Sacramento, CA
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) - NCT00303459-02111
Conditions: Pulmonary Hypertension
Location: Boston, MA
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) - NCT00303459-02115
Conditions: Pulmonary Hypertension
Location: Boston, MA
|
|